Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *British journal of cancer

Results: 76-100/6233

Authors: Pavillard, V Kherfellah, D Richard, S Robert, J Montaudon, D
Citation: V. Pavillard et al., Effects of the combination of camptothecin and doxorubicin or etoposide onrat glioma cells and camptothecin-resistant variants, BR J CANC, 85(7), 2001, pp. 1077-1083

Authors: Gatta, G Capocaccia, R Berrino, F
Citation: G. Gatta et al., Cancer survival differences between European populations: the UK uneasiness, BR J CANC, 85(6), 2001, pp. 785-786

Authors: Woodman, CBJ Gibbs, A Scott, N Haboubi, NY Collins, S
Citation: Cbj. Woodman et al., Are differences in stage at presentation a credible explanation for reported differences in the survival of patients with colorectal cancer in Europe?, BR J CANC, 85(6), 2001, pp. 787-790

Authors: Lantzsch, T Wolters, M Grimm, J Mende, T Buchmann, J Sliutz, G Koelbl, H
Citation: T. Lantzsch et al., Sentinel node procedure in Ib cervical cancer: a preliminary series, BR J CANC, 85(6), 2001, pp. 791-794

Authors: Coradini, D Boracchi, P Daidone, MG Pellizzaro, C Miodini, P Ammatuna, M Tomasic, G Biganzoli, E
Citation: D. Coradini et al., Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer, BR J CANC, 85(6), 2001, pp. 795-797

Authors: Kalbakis, K Kouroussis, C Kakolyris, S Mavroudis, D Souglakos, J Agelaki, S Vamvakas, L Christodoulakis, M Stylianou, K Georgoulias, V
Citation: K. Kalbakis et al., Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuousinfusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes, BR J CANC, 85(6), 2001, pp. 798-802

Authors: Melia, J Moss, S Coleman, D Frost, T Graham-Brown, R Hunter, JAA Marsden, RA du Vivier, A Warin, AP White, J Whitehead, SM Wroughton, MA
Citation: J. Melia et al., The relation between mortality from malignant melanoma and early detectionin the Cancer Research Campaign Mole Watcher Study, BR J CANC, 85(6), 2001, pp. 803-807

Authors: Lebitasy, MP Hedelin, G Purohit, A Moreau, L Klinzig, F Quoix, E
Citation: Mp. Lebitasy et al., Progress in the management and outcome of small-cell lung cancer in a French region from 1981 to 1994, BR J CANC, 85(6), 2001, pp. 808-815

Authors: Ray-Coquard, I Ghesquiere, H Bachelot, T Borg, C Biron, P Sebban, C LeCesne, A Chauvin, F Blay, JY
Citation: I. Ray-coquard et al., Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas, BR J CANC, 85(6), 2001, pp. 816-822

Authors: von Schlippe, M Fowler, CJ Harland, SJ
Citation: M. Von Schlippe et al., Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis, BR J CANC, 85(6), 2001, pp. 823-826

Authors: Iacopetta, B Grieu, F Joseph, D Elsaleh, H
Citation: B. Iacopetta et al., A polymorphism in the enhancer region of the thymidylate synthase promoterinfluences the survival of colorectal cancer patients treated with 5-fluorouracil, BR J CANC, 85(6), 2001, pp. 827-830

Authors: Anderson, J Gordon, T McManus, A Mapp, T Gould, S Kelsey, A McDowell, H Pinkerton, R Shipley, J Pritchard-Jones, K
Citation: J. Anderson et al., Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?, BR J CANC, 85(6), 2001, pp. 831-835

Authors: Della Torre, G Pasini, B Frigerio, S Donghi, R Rovini, D Delia, D Peters, G Huot, TJG Bianchi-Scarra, G Lantieri, F Rodolfo, M Parmiani, G Pierotti, MA
Citation: G. Della Torre et al., CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation, BR J CANC, 85(6), 2001, pp. 836-844

Authors: Casadei, S Cortesi, L Pensotti, V Radice, P Pierotti, M Amadori, D Calistri, D
Citation: S. Casadei et al., Detection of germline BRCA1 mutations by multiple-dye cleavase fragment length polymorphism (MD-CFLP) method, BR J CANC, 85(6), 2001, pp. 845-849

Authors: Steinmann, D Bremer, M Rades, D Skawran, B Siebrands, C Karstens, JH Dork, T
Citation: D. Steinmann et al., Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer, BR J CANC, 85(6), 2001, pp. 850-858

Authors: Bergman-Jungestrom, M Wingren, S
Citation: M. Bergman-jungestrom et S. Wingren, Catechol-O-Methyltransferase (COMT) gene polymorphism and breast cancer risk in young women, BR J CANC, 85(6), 2001, pp. 859-862

Authors: Edwards, JG Cox, G Andi, A Jones, JL Walker, RA Waller, DA O'Byrne, KJ
Citation: Jg. Edwards et al., Angiogenesis is an independent prognostic factor in malignant mesothelioma, BR J CANC, 85(6), 2001, pp. 863-868

Authors: Warnberg, F Nordgren, H Bergkvist, L Holmberg, L
Citation: F. Warnberg et al., Tumour markers in breast carcinoma correlate with grade rather than with invasiveness, BR J CANC, 85(6), 2001, pp. 869-874

Authors: Czarnocka, B Pastuszko, D Janota-Bzowski, M Weetman, AP Watson, PF Kemp, EH McIntosh, RS Asghar, MS Jarzab, B Gubala, E Wioch, J Lange, D
Citation: B. Czarnocka et al., Is there loss or qualitative changes in the expression of thyroid peroxidase protein in thyroid epithelial cancer?, BR J CANC, 85(6), 2001, pp. 875-880

Authors: Giatromanolaki, A Koukourakis, MI Sivridis, E Turley, H Talks, K Pezzella, F Gatter, KC Harris, AL
Citation: A. Giatromanolaki et al., Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival, BR J CANC, 85(6), 2001, pp. 881-890

Authors: Scotton, C Milliken, D Wilson, J Raju, S Balkwill, F
Citation: C. Scotton et al., Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours, BR J CANC, 85(6), 2001, pp. 891-897

Authors: Narayan, S Jaiswal, AS Multani, AS Pathak, S
Citation: S. Narayan et al., DNA damage-induce cell cycle checkpoints involve both p53-dependent and -independent pathways: role of telomere repeat binding factor 2, BR J CANC, 85(6), 2001, pp. 898-901

Authors: Galmarini, CM Falette, N Tabone, E Levrat, C Britten, R Voorzanger-Rousselot, N Roesch-Gateau, O Vanier-Viornery, A Puisieux, A Dumontet, C
Citation: Cm. Galmarini et al., Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity, BR J CANC, 85(6), 2001, pp. 902-908

Authors: Andronicos, NM Ranson, M
Citation: Nm. Andronicos et M. Ranson, The topology of plasminogen binding and activation on the surface of humanbreast cancer cells, BR J CANC, 85(6), 2001, pp. 909-916

Authors: Di Benedetto, M Kourbali, Y Starzec, A Vassy, R Jozefonvicz, J Perret, G Crepin, M Kraemer, M
Citation: M. Di Benedetto et al., Sodium phenylacetate enhances the inhibitory effect of dextran derivative on breast cancer cell growth in vitro and in nude mice, BR J CANC, 85(6), 2001, pp. 917-923
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>